PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
暂无分享,去创建一个
Daniel G Tenen | Carsten Müller-Tidow | Pier Giuseppe Pelicci | D. Tenen | G. Behre | P. Pelicci | D. Niederwieser | C. Müller-Tidow | Jens Hartmann | Dietger Niederwieser | Gerhard Behre | Maria Vittoria Verga Falzacappa | Daniela Bräuer-Hartmann | Jens-Uwe Hartmann | Alexander Arthur Wurm | Dennis Gerloff | Christiane Katzerke | M. V. Verga Falzacappa | C. Katzerke | D. Gerloff | D. Bräuer-Hartmann | A. Wurm | Alexander A. Wurm | Dennis Gerloff | Christiane Katzerke
[1] J. Reilly,et al. Aberrant methylation of the negative regulators RASSFIA, SHP‐1 and SOCS‐1 in myelodysplastic syndromes and acute myeloid leukaemia , 2005, British journal of haematology.
[2] Stefano Volinia,et al. miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. , 2011, Blood.
[3] Bob Löwenberg,et al. MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. , 2008, Blood.
[4] C. Croce,et al. MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia , 2007, Oncogene.
[5] Alessandro Fatica,et al. A Minicircuitry Comprised of MicroRNA-223 and Transcription Factors NFI-A and C/EBPα Regulates Human Granulopoiesis , 2005, Cell.
[6] F. Végran,et al. STAT3 activation , 2013, JAK-STAT.
[7] Fang Wang,et al. Human microRNA clusters: genomic organization and expression profile in leukemia cell lines. , 2006, Biochemical and biophysical research communications.
[8] S. Minucci,et al. Methyltransferase Recruitment and DNA Hypermethylation of Target Promoters by an Oncogenic Transcription Factor , 2002, Science.
[9] J. Minna,et al. The RASSF1A Tumor Suppressor Blocks Cell Cycle Progression and Inhibits Cyclin D1 Accumulation , 2002, Molecular and Cellular Biology.
[10] Xiuping Liu,et al. Functional analysis of microRNAs in human hepatocellular cancer stem cells , 2011, Journal of cellular and molecular medicine.
[11] M. Caligiuri,et al. Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia. , 2013, Blood.
[12] M. Caligiuri,et al. Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. , 2012, Blood.
[13] Y. Pekarsky,et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. , 2006, Cancer research.
[14] C. Croce,et al. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: A circuit diagram of differentiation control , 2006, Proceedings of the National Academy of Sciences.
[15] Elodie Portales-Casamar,et al. Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia. , 2009, Blood.
[16] Zhen-yi Wang,et al. Acute promyelocytic leukemia: from highly fatal to highly curable. , 2008, Blood.
[17] D. Tenen,et al. Transcription factor C/EBPα-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia. , 2013, Blood.
[18] D. Tenen,et al. NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia , 2014, Leukemia.
[19] K. Ghoshal,et al. TGFβ mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3 , 2009, Oncogene.
[20] H. Donninger,et al. The RASSF1A tumor suppressor , 2007, Journal of Cell Science.
[21] S. Collins,et al. Terminal Differentiation of Human Promyelocytic Leukemic Cells in Primary Culture in Response to Retinoic Acid , 1981 .
[22] S. Lowe,et al. The microcosmos of cancer , 2012, Nature.
[23] F. Lo‐Coco,et al. A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytes , 2009, Oncogene.
[24] Christine Chomienne,et al. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR , 1991, Cell.
[25] M. Yi,et al. RASSF1A suppresses melanoma development by modulating apoptosis and cell‐cycle progression , 2011, Journal of cellular physiology.
[26] T. Golub,et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations , 2008, Proceedings of the National Academy of Sciences.
[27] A. Bell,et al. Ras Uses the Novel Tumor Suppressor RASSF1 as an Effector to Mediate Apoptosis* , 2000, The Journal of Biological Chemistry.
[28] Myriam Alcalay,et al. The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells , 1993, Cell.
[29] Daniel G Tenen,et al. C/EBPβ: a major PML–RARA‐responsive gene in retinoic acid‐induced differentiation of APL cells , 2003, The EMBO journal.
[30] T. Triche,et al. Retinoid-induced G1 Arrest and Differentiation Activation Are Associated with a Switch to Cyclin-dependent Kinase-activating Kinase Hypophosphorylation of Retinoic Acid Receptor α* , 2002, The Journal of Biological Chemistry.
[31] Jian-yong Li,et al. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. , 2012, Carcinogenesis.
[32] A. Fatica,et al. Role of microRNAs in myeloid differentiation. , 2008, Biochemical Society transactions.
[33] Mark M. Davis,et al. miR-181a Is an Intrinsic Modulator of T Cell Sensitivity and Selection , 2007, Cell.
[34] D. Bartel,et al. MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.
[35] F. Latif,et al. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. , 2005, Cancer research.
[36] J. Licht,et al. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. , 1999, Blood.
[37] Youhong Liu,et al. Activation of the p38 MAPK/Akt/ERK1/2 signal pathways is required for the protein stabilization of CDC6 and cyclin D1 in low‐dose arsenite‐induced cell proliferation , 2010, Journal of cellular biochemistry.
[38] P. Pandolfi,et al. Pml is essential for multiple apoptotic pathways , 1998, Nature Genetics.
[39] T Chaplin,et al. MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis , 2007, Leukemia.
[40] Kevin Struhl,et al. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. , 2010, Molecular cell.
[41] Jonathan D. Licht,et al. Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia , 1999 .
[42] M. Omrani,et al. Intact expression status of RASSF1A in acute myeloid leukemia , 2013, Medical Oncology.
[43] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[44] J. Licht. Reconstructing a disease: What essential features of the retinoic acid receptor fusion oncoproteins generate acute promyelocytic leukemia? , 2006, Cancer cell.
[45] G. Behre,et al. Chromatin modifications induced by PML-RARalpha repress critical targets in leukemogenesis as analyzed by ChIP-Chip. , 2008, Blood.
[46] J. Chen,et al. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets , 2014, Oncogene.
[47] Daniel G Tenen,et al. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. , 2010, Blood.
[48] Michael A McDevitt,et al. Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation , 2010, Leukemia & lymphoma.
[49] D. Tenen,et al. Proteomic analysis of acute promyelocytic leukemia: PML‐RARα leads to decreased phosphorylation of OP18 at serine 63 , 2006, Proteomics.
[50] R. Garzon,et al. MicroRNAs: new players in acute myeloid leukaemia , 2009, British Journal of Cancer.
[51] S. Bohlander,et al. C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. , 2010, Blood.
[52] T. Ley,et al. High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression. , 2003, Blood.